Handelsbanken Fonder AB Acquires 14,919 Shares of Cardinal Health, Inc. $CAH

Handelsbanken Fonder AB increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 12.5% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 133,971 shares of the company’s stock after purchasing an additional 14,919 shares during the quarter. Handelsbanken Fonder AB’s holdings in Cardinal Health were worth $31,826,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CAH. University of Texas Texas AM Investment Management Co. acquired a new position in shares of Cardinal Health during the fourth quarter worth approximately $26,000. Bank of Jackson Hole Trust purchased a new stake in shares of Cardinal Health in the fourth quarter valued at about $27,000. Jones Financial Companies Lllp lifted its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. Palladiem LLC bought a new stake in Cardinal Health during the fourth quarter worth $28,000. Finally, Indiana Trust & Investment Management Co bought a new stake in shares of Cardinal Health during the 1st quarter worth $29,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently commented on CAH. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Weiss Ratings raised shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a report on Wednesday, August 5th. Zacks Research downgraded Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. UBS Group lifted their target price on shares of Cardinal Health from $260.00 to $274.00 and gave the company a “buy” rating in a research report on Monday, July 20th. Finally, Robert W. Baird set a $248.00 price target on Cardinal Health in a research note on Friday, May 1st. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $252.87.

Key Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Earnings beat expectations: Fourth-quarter non-GAAP EPS was $2.91, well above the $2.42 analyst consensus and up from $2.08 a year earlier. Revenue rose 6% year over year to $63.7 billion, although it fell short of estimates near $65.15 billion. CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock Up
• Positive Sentiment: Above-consensus fiscal 2027 guidance: Cardinal Health forecast adjusted EPS of $12.40 to $12.60, representing 13% to 15% growth and exceeding the $12.05 consensus. Management cited continued strength in specialty pharmaceuticals. Cardinal Health forecasts full-year profit above estimates on specialty drug strength
• Positive Sentiment: Large buyback authorization: The board approved an additional $5 billion for share repurchases, following $1.4 billion of buybacks completed during fiscal 2026. The authorization could support EPS growth and shareholder returns.
• Positive Sentiment: Growth in cell- and gene-therapy logistics: Cardinal added two commercialization agreements and now exclusively serves nearly half of the cell- and gene-therapy market, a higher-margin growth opportunity than traditional drug distribution. Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market
• Positive Sentiment: Dividend maintained: Cardinal Health declared a quarterly dividend of $0.5158 per share, payable October 15 to shareholders of record October 1. Cardinal Health Board of Directors Approves Quarterly Dividend
• Neutral Sentiment: Mixed quarter and valuation concerns: The revenue shortfall and weakness in Global Medical Products and Distribution tempered the results. About $0.31 of quarterly adjusted EPS benefited from a one-time tariff refund, while the stock’s recent rally and elevated valuation may encourage profit-taking.

Cardinal Health Trading Up 1.2%

Shares of NYSE:CAH opened at $240.08 on Wednesday. The company has a market cap of $56.23 billion, a price-to-earnings ratio of 36.71, a price-to-earnings-growth ratio of 1.16 and a beta of 0.49. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $258.30. The company has a 50-day moving average price of $228.37 and a 200-day moving average price of $216.66.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.Cardinal Health’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s payout ratio is 31.50%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.